Substitute

There have been a couple of tangible measures announced for the healthcare, pharma and biotech sectors which justifies the…

The budget doesn’t have any special announcements with respect to the pharma industry except strengthening of drug testing…

The budget fell short of expectations while the market was looking forward to some meaningful reforms. What we found instead, were…

I feel the Government has done a commendable job with the Union budget considering that it been in office barely for six weeks.…

Biogen Idec prides itself in the business of transforming lives of patients. Corporate citizenship is deeply ingrained into the…

Innovation is intrinsic to human nature but very often, the impact of these remain restricted to a small circle. A…

The Companies Bill 2012 makes it compulsory for the corporate houses to indulge in Corporate Social Responsibility (CSR)…

Novartis India is globally known for its quality medicines. The company has managed to save millions of lives across the globe…

A public listed pharmaceutical company, Abbott India is a part of Abbott’s global pharma business in India. The company believes…

With an aim to provide better healthcare access at affordable cost to all people living in the Indian society, Strand Life…

Sciformix Corporation is a Scientific Process Organization (SPO), providing scientific knowledge-based services to pharmaceutical…

Piramal Foundation runs initiatives that all contribute in nation building. Its focus areas are health, education, youth…

Healthcare experts have constantly raised questions over the standards of child healthcare in India. Being an important…

It is very usual to see companies working in the healthcare industry doing CSR activities. However, there are companies from other…

At Venus Remedies, corporate social responsibility is not a modular add-on to the business; it is core to the business itself. The…

AstraZeneca India, established in 1979 and head-quartered at Bengaluru, Karnataka believes in improving health which is one of the…

In its pre-budget memorandum, the Organisation of Pharmaceutical Producers of India (OPPI) proposed budgetary measures in key…

Bourgeoning population, growing incidence of chronic and lifestyle diseases and increasing healthcare costs are calling for…

It is high time that the Government takes a serious note of the issues and concerns of the Indian pharmaceutical industry. The…

Make bio-manufacturing the next big opportunity after generics for India. Invest $4-5 billion each year (Rs 24,000 to 30,000…